Colon cancer (ICD C18) is one of the five most common malignant tumors in the world, ranking third overall. While the average age of most patients is 60-75 years, the disease can also develop in individuals between 35-50 years old. Favorable treatment outcomes and colon cancer prognosis, even at stage 4 cancer, can be achieved with the usage...

Ovarian cancer is one of the most common gynecologic cancers, it ranks second in incidence among all types of cancer. It is most often diagnosed in women over 40-45 years old. Screening and increased awareness are crucial in detecting ovarian cancer early before it reaches stage 4, a terminal phase often accompanied by severe pain...

The European Society for Medical Oncology annually updates its recommendations for the treatment of pancreatic cancer, including stage 4 pancreatic cancer treatment. This is due to the active development of new therapeutic methods for improving the quality of life and longevity of people with this diagnosis.

Patients with an established diagnosis of prostate cancer often face a difficult choice: either to undergo invasive treatment that may cause severe side effects or to choose a watchful waiting strategy while maintaining quality of life but risking disease progression. VTP TOOKAD® focal therapy is an innovative solution that allows for...

Esophageal cancer is one of the twenty most widespread cancer types. The disease can develop at any age, but most often it is diagnosed over the age of 60, when treatment options are already somewhat limited by the patient's chronic conditions. Patients who undergo treatment in Germany have a chance to significantly increase...

Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year. This tumor accounts for 3% of all cancers, which is a fairly high figure. The treatment methods offered in Germany allow for achieving excellent results, even at stage 4 of the pathology.

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment option for peritoneal carcinomatosis. The technique was developed in 2011 by scientists from the University Hospital of Louisiana, USA. The authors suggested PIPAC as an alternative to HIPEC (hyperthermic intraperitoneal chemotherapy) in patients with peritoneal...

In 2022, Europe broke the record of ovarian cancer incidence and mortality – the highest rates among all other countries in the world. Breast cancer among European women is also on the third place in the world in terms of incidence. This may be one of the reasons why German oncologists strive to gain expertise in the treatment of patients with cancer...